16
Publications
1.4K
Citations
13
H-Index
1998
Active since
Bérengère Sauvagnat is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in engineering, biomolecular engineering, and natural sciences.
Top concepts
EngineeringBiomolecular EngineeringChemistryNatural SciencesMedicinePharmacologyDrug DiscoveryOrganic ChemistryBiochemistryMedicinal Chemistry
Publications per year
1998–2023
16
16
An orally available non-nucleotide STING agonist with antitumor activity
Bo‐Sheng Pan, Samanthi A. Perera, Jennifer Piesvaux et al. · Science · 2020 · 609 citations
Nanoscale synthesis and affinity ranking
Nathan J. Gesmundo, Bérengère Sauvagnat, Patrick J. Curran et al. · Nature · 2018 · 201 citations
Discovery of a Novel cGAMP Competitive Ligand of the Inactive Form of STING
Tony Siu, Michael D. Altman, Gretchen A. Baltus et al. · ACS Medicinal Chemistry Letters · 2018 · 163 citations · Full text
Rows per page
1–5 of 16